Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Johnson

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Diabetes|April 28, 2005
Inhibitory effects of antipsychotics on carbachol-enhanced insulin secretion from perifused rat islets: role of muscarinic antagonism in antipsychotic-induced diabetes and hyperglycemiaDavid E Johnson, Hanae Yamazaki, Karen M Ward, et al.
Cell Reports|January 25, 2026
Oncogenic influences of neurotrophin receptors: Shedding light on Trk biologyHawa L Jagana, Maryam M Shabar, Taylor S Jackson, et al.
Prehospital Emergency Care|June 29, 2017
Medical Oversight, Educational Core Content, and Proposed Scopes of Practice of Wilderness EMS Providers: A Joint Project Developed by Wilderness EMS Educators, Medical Directors, and Regulators Using a Delphi ApproachMichael G Millin, David E Johnson, Tod Schimelpfenig, et al.
Infection and Immunity|June 24, 2004
Identification and characterization of a novel uropathogenic Escherichia coli-associated fimbrial gene clusterEric L Buckles, Farah K Bahrani-Mougeot, Anita Molina, et al.
Journal of Neuroscience Methods|September 5, 2018
Maximising coverage of brain structures using controlled reflux, convection-enhanced delivery and the recessed step catheterOwen Lewis, Max Woolley, David E Johnson, et al.
Biochemical Pharmacology|June 9, 2009
Preclinical pharmacology of the alpha4beta2 nAChR partial agonist varenicline related to effects on reward, mood and cognitionHans Rollema, Mihály Hajós, Patricia A Seymour, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 13, 2012
The 5-hydroxytryptamine4 receptor agonists prucalopride and PRX-03140 increase acetylcholine and histamine levels in the rat prefrontal cortex and the power of stimulated hippocampal θ oscillationsDavid E Johnson, Elena Drummond, Sarah Grimwood, et al.
Bulletin of the World Health Organization|July 12, 2021
Emergency care with lay responders in underserved populations: a systematic reviewAaron M Orkin, Jeyasakthi Venugopal, Jeffrey D Curran, et al.
Frontiers in Pharmacology|August 1, 2020
Characterization of PF-6142, a Novel, Non-Catecholamine Dopamine Receptor D1 Agonist, in Murine and Nonhuman Primate Models of Dopaminergic ActivationRouba Kozak, Tamás Kiss, Keith Dlugolenski, et al.
Journal of Medicinal Chemistry|September 15, 2012
Identification of multiple 5-HT₄ partial agonist clinical candidates for the treatment of Alzheimer's diseaseMichael A Brodney, David E Johnson, Aarti Sawant-Basak, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Diabetes|April 28, 2005
Inhibitory effects of antipsychotics on carbachol-enhanced insulin secretion from perifused rat islets: role of muscarinic antagonism in antipsychotic-induced diabetes and hyperglycemiaDavid E Johnson, Hanae Yamazaki, Karen M Ward, et al.
Cell Reports|January 25, 2026
Oncogenic influences of neurotrophin receptors: Shedding light on Trk biologyHawa L Jagana, Maryam M Shabar, Taylor S Jackson, et al.
Prehospital Emergency Care|June 29, 2017
Medical Oversight, Educational Core Content, and Proposed Scopes of Practice of Wilderness EMS Providers: A Joint Project Developed by Wilderness EMS Educators, Medical Directors, and Regulators Using a Delphi ApproachMichael G Millin, David E Johnson, Tod Schimelpfenig, et al.
Infection and Immunity|June 24, 2004
Identification and characterization of a novel uropathogenic Escherichia coli-associated fimbrial gene clusterEric L Buckles, Farah K Bahrani-Mougeot, Anita Molina, et al.
Journal of Neuroscience Methods|September 5, 2018
Maximising coverage of brain structures using controlled reflux, convection-enhanced delivery and the recessed step catheterOwen Lewis, Max Woolley, David E Johnson, et al.
Biochemical Pharmacology|June 9, 2009
Preclinical pharmacology of the alpha4beta2 nAChR partial agonist varenicline related to effects on reward, mood and cognitionHans Rollema, Mihály Hajós, Patricia A Seymour, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 13, 2012
The 5-hydroxytryptamine4 receptor agonists prucalopride and PRX-03140 increase acetylcholine and histamine levels in the rat prefrontal cortex and the power of stimulated hippocampal θ oscillationsDavid E Johnson, Elena Drummond, Sarah Grimwood, et al.
Bulletin of the World Health Organization|July 12, 2021
Emergency care with lay responders in underserved populations: a systematic reviewAaron M Orkin, Jeyasakthi Venugopal, Jeffrey D Curran, et al.
Frontiers in Pharmacology|August 1, 2020
Characterization of PF-6142, a Novel, Non-Catecholamine Dopamine Receptor D1 Agonist, in Murine and Nonhuman Primate Models of Dopaminergic ActivationRouba Kozak, Tamás Kiss, Keith Dlugolenski, et al.
Journal of Medicinal Chemistry|September 15, 2012
Identification of multiple 5-HT₄ partial agonist clinical candidates for the treatment of Alzheimer's diseaseMichael A Brodney, David E Johnson, Aarti Sawant-Basak, et al.
Pageof 6